In collaboration with Switzerland, Latvia is working on improving the approach to diagnosis and personalised treatment by creating a monitoring system for long-term support of children with cancer. In the future, this system will also be developed for adult oncological and rare disease. This project uses advanced genetic diagnostics and artificial intelligence (AI) to analyse patient data and create personalised treatment plans for patients.
Initiative overview
The project combines advanced genetic diagnostics with AI-based analysis to inform personalised treatment. Alongside building the monitoring infrastructure, the programme emphasises clinical pathway development and knowledge exchange between Latvian and Swiss institutions to strengthen precision oncology capacity.